RxDoctor Payments Data

Than Luu, MD

Family Medicine · Rosemead, CANPI 1750548640

Payments from drug & device makers

$25,213in general payments, 2019–2025

Across 860 payments — averaging $29.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Amgen$3K
  • AstraZeneca$2K
  • GSK$1K
  • Gilead$1K
  • Biohaven Pharmaceuticals, Inc.$1K
  • plus $12K from 48 others

What the payments were for

  • Consulting fees$1,2005%
  • Food & beverage$23,99395%
  • Education$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,213 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$22,138
Medicare patients
110
Services billed
246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol273$199,646
KerendiaFinerenone193$153,454
CreonLipase/Protease/Amylase106$147,310
LinzessLinaclotide223$126,234
VemlidyTenofovir Alafenamide77$122,193
JanuviaSitagliptin Phosphate160$118,745
Diclofenac Sodium275$117,574
RybelsusSemaglutide82$113,889
Hydrocortisone115$99,502
VascepaIcosapent Ethyl164$70,934
Diclofenac Epolamine104$64,408
DapagliflozinDapagliflozin Propanediol114$63,675
HorizantGabapentin Enacarbil73$54,963
ProliaDenosumab30$50,101
Cyclosporine128$42,967

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess, Restasis$3,775$304,460375 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,911$212,638287 claims
BayerKerendia$1,124$153,454193 claims
MerckJanuvia, Janumet$36$145,785202 claims
Novo NordiskRybelsus, Ozempic$1,214$143,060110 claims
GileadVemlidy$1,325$122,19377 claims
Boehringer IngelheimJardiance, Combivent Respimat, Tradjenta$440$68,933107 claims
Arbor Pharmaceuticals, Inc.Horizant$20$54,96373 claims
AmgenProlia$3,126$50,10130 claims
IBSA Pharma Inc.Licart$477$42,66353 claims
Sun Pharmaceutical Industries Inc.Cequa$461$32,60156 claims
PfizerEliquis$695$30,93434 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,533 family medicine providers in California.

Other family medicine in Rosemead

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →